Surgery Partners (NASDAQ:SGRY) Price Target Raised to $25.00

Surgery Partners (NASDAQ:SGRY – Free Report) had its price target hoisted by Royal Bank Of Canada from $23.50 to $25.00 in a research report released on Tuesday,Benzinga reports. Royal Bank Of Canada currently has a sector perform rating on the stock.

SGRY has been the subject of several other research reports. Zacks Research downgraded shares of Surgery Partners from a “strong-buy” rating to a “hold” rating in a research note on Monday, August 10th. JPMorgan Chase & Co. lifted their target price on Surgery Partners from $14.00 to $15.00 and gave the stock a “neutral” rating in a research report on Monday, September 14th. UBS Group cut Surgery Partners from a “buy” rating to a “hold” rating and lifted their target price for the stock from $21.00 to $23.50 in a research report on Wednesday, October 28th. Cantor Fitzgerald downgraded Surgery Partners from an “overweight” rating to a “hold” rating in a report on Monday, October 26th. Finally, Benchmark reissued a “buy” rating on shares of Surgery Partners in a research report on Tuesday, August 11th. Two analysts have rated the stock with a Buy rating, nine have issued a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, the company has a consensus rating of “Hold” and a consensus price target of $20.70.

Check Out Our Latest Stock Analysis on SGRY

Surgery Partners Trading Down 0.3%

Shares of Surgery Partners stock opened at $26.58 on Tuesday. The company has a fifty day simple moving average of $17.04 and a 200-day simple moving average of $15.04. Surgery Partners has a 12-month low of $11.41 and a 12-month high of $27.23. The company has a current ratio of 2.17, a quick ratio of 1.78 and a debt-to-equity ratio of 1.03. The stock has a market cap of $3.48 billion, a price-to-earnings ratio of 126.95 and a beta of 1.85.

Surgery Partners (NASDAQ:SGRY – Get Free Report) last posted its earnings results on Monday, November 9th. The company reported $0.16 EPS for the quarter, beating analysts’ consensus estimates of $0.11 by $0.05. Surgery Partners had a negative net margin of 2.59% and a positive return on equity of 0.98%. The firm had revenue of $815.30 million for the quarter, compared to the consensus estimate of $820.96 million. During the same period last year, the firm posted $0.13 EPS. The company’s revenue was down .8% on a year-over-year basis. On average, equities analysts forecast that Surgery Partners will post 0.07 EPS for the current fiscal year.

Insider Activity at Surgery Partners

In other Surgery Partners news, Director Teresa DeLuca bought 10,000 shares of the business’s stock in a transaction dated Tuesday, August 18th. The shares were acquired at an average cost of $14.35 per share, with a total value of $143,500.00. Following the acquisition, the director directly owned 66,843 shares of the company’s stock, valued at $959,197.05. The trade was a 17.59% increase in their position. The purchase was disclosed in a legal filing with the SEC, which is accessible through this link. 2.00% of the stock is owned by insiders.

Institutional Trading of Surgery Partners

A number of large investors have recently bought and sold shares of SGRY. Public Employees Retirement System of Ohio purchased a new position in Surgery Partners during the 2nd quarter worth $38,000. PNC Financial Services Group Inc. raised its holdings in shares of Surgery Partners by 239.6% in the first quarter. PNC Financial Services Group Inc. now owns 2,907 shares of the company’s stock valued at $35,000 after buying an additional 2,051 shares during the last quarter. Fifth Third Bancorp raised its holdings in shares of Surgery Partners by 5,324.0% in the first quarter. Fifth Third Bancorp now owns 4,068 shares of the company’s stock valued at $48,000 after buying an additional 3,993 shares during the last quarter. Empowered Funds LLC purchased a new stake in shares of Surgery Partners in the second quarter valued at about $216,000. Finally, Vise Technologies Inc. purchased a new stake in shares of Surgery Partners in the third quarter valued at about $191,000.

Surgery Partners Company Profile

(Get Free Report)

Surgery Partners, Inc. is a U.S. healthcare services company that owns and operates ambulatory surgery centers and surgical hospitals. Its facilities provide outpatient and inpatient surgical care across a range of specialties. The company’s services include surgical procedures and related care delivered in partnership with physicians and healthcare professionals. Its network serves patients in multiple states across the United States. Founded in 2004, Surgery Partners has expanded its network through acquisitions and partnerships with physicians and health systems.

Featured Articles

Analyst Recommendations for Surgery Partners (NASDAQ:SGRY)

Receive News & Ratings for Surgery Partners Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Surgery Partners and related companies with MarketBeat.com's FREE daily email newsletter.